Failure (biologic function) – Page 4

Roche’s TIGIT Drug Tiragolumab Fails Another Phase 3 Lung Cancer Trial

11 months ago talkbio0Tagged Failure (biologic function), Keytruda, Malignant neoplasm of lung, Phase 3 trial, Roche (company), Tecentriq, TIGIT gene, Tiragolumab

Roche, TIGIT, tiragolumab, lung cancer, Phase 3 trial, failure, Keytruda, Tecentriq

Ozempic Reduces Mortality Risk by 20% in Diabetes Patients with Chronic Kidney Disease

1 year ago1 year ago talkbio0Tagged Cardiovascular system, Cessation of life, Chronic Kidney Diseases, Diabetes, Failure (biologic function), Kidney, Mortality Vital Statistics, Nordisk, Obesity, semaglutide, Wegovy

** Ozempic, Novo Nordisk, diabetes, chronic kidney disease, mortality risk, cardiovascular deaths, kidney failure, semaglutide, Wegovy, obesity treatment

Detailed PHOENIX Study Reveals Relyvrio’s Failure in ALS Treatment

1 year ago talkbio0Tagged Amylyx, Amyotrophic Lateral Sclerosis, Clinical Research, Clinical Trials, Failure (biologic function), Phoenix Pharmaceuticals, Relyvrio

Relyvrio, PHOENIX study, Amyotrophic Lateral Sclerosis (ALS), Trial failure, Amylyx Pharmaceuticals

Amylyx’s ALS Treatment Relyvrio Disappoints in Phase III PHOENIX Study, Company Considering Market Withdrawal

1 year ago talkbio0Tagged Amylyx, Amyotrophic Lateral Sclerosis, Clinical Trials, Failure (biologic function), Market, Phase III PHOENIX Study, Placebos, Relyvrio, Statistical Significance, Withdraw (activity)

Amylyx, Relyvrio, ALS, Failure, Phase III PHOENIX Study, Market Withdrawal, Clinical Trial, Placebo, No Statistical Significance